Viatris (VTRS) Change in Account Payables (2020 - 2026)
Viatris (VTRS) posted quarterly Change in Account Payables of $32.7 million for Q1 2026, down 67.81% year-over-year from $101.6 million in Q1 2025, and up 76.76% quarter-over-quarter from $18.5 million in Q4 2025.
Viatris (VTRS) Change in Account Payables (2020 - 2026) Analysis & Trends
Viatris' Change in Account Payables history runs 7 years deep, the most recent figure standing at $32.7 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 67.81% year-over-year to $32.7 million; the TTM figure through Mar 2026 stood at -$236.9 million (down 57.62% YoY), while the FY2025 annual figure was -$168.0 million, down 566.67% from the prior year.
- Change in Account Payables for Q1 2026 stood at $32.7 million, up from $18.5 million in the prior quarter.
- The five-year high for Change in Account Payables was $287.9 million in Q1 2024, with the low at -$329.9 million in Q3 2022.
- The 5-year median for Change in Account Payables is $32.7 million (2026), against an average of $22.7 million.
- The sharpest annual moves came in 2023 and 2024: Change in Account Payables surged 707.28% in 2023, then sank 2590.32% in 2024.
- Viatris' Change in Account Payables stood at $245.6 million in 2022, then slumped by 68.08% to $78.4 million in 2023, then plunged by 41.71% to $45.7 million in 2024, then plunged by 59.52% to $18.5 million in 2025, then surged by 76.76% to $32.7 million in 2026.
- Business Quant data shows VTRS's Change in Account Payables at $32.7 million in Q1 2026, $18.5 million in Q4 2025, and $3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Alkermes | 8.17 Bn | 7.51 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.20 Mn |
| Jun 30, 2026 | -21.20 Mn |
| Mar 31, 2026 | 32.70 Mn |
| Mar 31, 2026 | 32.70 Mn |
| Dec 31, 2025 | 18.50 Mn |
| Dec 31, 2025 | 18.50 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | -291.30 Mn |
| Jun 30, 2025 | -291.30 Mn |
| Mar 31, 2025 | 101.60 Mn |
| Mar 31, 2025 | 101.60 Mn |
| Dec 31, 2024 | 45.70 Mn |
| Dec 31, 2024 | 45.70 Mn |
| Sep 30, 2024 | -66.00 Mn |
| Sep 30, 2024 | -66.00 Mn |
| Jun 30, 2024 | -231.60 Mn |
| Jun 30, 2024 | -231.60 Mn |
| Mar 31, 2024 | 287.90 Mn |
| Mar 31, 2024 | 287.90 Mn |